|
DE3933850A1
(de)
|
1989-10-06 |
1991-04-18 |
Schering Ag |
Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins
|
|
EP0614984B2
(en)
|
1993-03-05 |
2010-11-03 |
Bayer HealthCare LLC |
Anti-TNF alpha human monoclonal antibodies
|
|
US5595756A
(en)
*
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US6383808B1
(en)
|
2000-09-11 |
2002-05-07 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of clusterin expression
|
|
US6818749B1
(en)
|
1998-10-31 |
2004-11-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Variants of humanized anti carcinoma monoclonal antibody cc49
|
|
AU3116800A
(en)
|
1998-12-11 |
2000-06-26 |
Research Foundation Of The State University Of New York, The |
Compositions and methods for altering cell migration
|
|
ATE385237T1
(de)
|
1999-02-26 |
2008-02-15 |
Univ British Columbia |
Antisense-therapie für trpm-2
|
|
US6900187B2
(en)
|
1999-02-26 |
2005-05-31 |
The University Of British Columbia |
TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
|
|
IL145941A
(en)
|
1999-04-28 |
2007-08-19 |
Univ Texas |
Compositions and methods for cancer treatment by selectively inhibiting vegf
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
|
US20050208558A1
(en)
|
1999-10-19 |
2005-09-22 |
Applera Corporation |
Detection kits, such as nucleic acid arrays, for detecting the expression or 10,000 or more Drosophila genes and uses thereof
|
|
US7569551B2
(en)
|
2000-02-25 |
2009-08-04 |
The University Of British Columbia |
Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
|
|
AU2001245280A1
(en)
|
2000-03-07 |
2001-09-17 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
AU2001253140A1
(en)
|
2000-04-03 |
2001-10-15 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Tumor markers in ovarian cancer
|
|
US6812339B1
(en)
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
CA2441495A1
(en)
|
2001-02-09 |
2002-09-19 |
Incyte Genomics, Inc. |
Proteins associated with cell growth, differentiation, and death
|
|
EP1419252A2
(en)
|
2001-04-04 |
2004-05-19 |
Merrion Research I Limited |
Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors
|
|
MXPA05000511A
(es)
|
2001-07-12 |
2005-09-30 |
Jefferson Foote |
Anticuepros super humanizados.
|
|
US20030134301A1
(en)
|
2001-07-27 |
2003-07-17 |
Brooksbank Robert Alan |
Identification and use of molecules implicated in pain
|
|
EP1478772A2
(en)
|
2001-08-14 |
2004-11-24 |
The General Hospital Corporation |
Nucleic acid and amino acid sequences involved in pain
|
|
US20040142325A1
(en)
|
2001-09-14 |
2004-07-22 |
Liat Mintz |
Methods and systems for annotating biomolecular sequences
|
|
EP1504099A4
(en)
|
2001-12-10 |
2006-05-10 |
Nuvelo Inc |
NEW NUCLEIC ACIDS AND POLYPEPTIDES
|
|
EP1465995B1
(en)
|
2002-01-17 |
2008-07-30 |
The University of British Columbia |
Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
|
|
CA2478063A1
(en)
|
2002-03-07 |
2003-10-02 |
Ludwig Institute For Cancer Research |
Lymphatic and blood endothelial cell genes
|
|
AU2003210060B2
(en)
|
2002-03-22 |
2010-02-25 |
Aprogen, Inc. |
Humanized antibody and process for preparing same
|
|
AU2003281287A1
(en)
|
2002-07-04 |
2004-01-23 |
Oxford Glycosciences (Uk) Ltd |
Toxicity markers
|
|
KR101117673B1
(ko)
|
2002-08-21 |
2012-03-07 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
암-관련 단백질을 표적으로 하는 알엔에이아이 프로브
|
|
PT1530636E
(pt)
|
2002-08-21 |
2010-11-17 |
Univ British Columbia |
Tratamento do melanoma por redução dos níveis de clusterina
|
|
EP2500438A3
(en)
|
2002-09-25 |
2012-11-28 |
Genentech, Inc. |
Novel compositions and methods for the treatment of psoriasis
|
|
US20050048490A1
(en)
|
2002-09-26 |
2005-03-03 |
Incyte Corp. |
Proteins associated with cell growth, differentiation, and death
|
|
US8722872B2
(en)
|
2002-10-02 |
2014-05-13 |
The University Of British Columbia |
Compositions and methods for treatment of prostate and other cancers
|
|
CA2500687A1
(en)
|
2002-10-02 |
2004-04-15 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
DE10256900A1
(de)
|
2002-11-29 |
2004-06-24 |
Nemod Immuntherapie Ag |
Tumorspezifische Erkennungsmoleküle
|
|
WO2004066941A2
(en)
|
2003-01-24 |
2004-08-12 |
Bayer Pharmaceuticals Corporation |
Expression profiles for colon cancer and methods of use
|
|
WO2005049806A2
(en)
|
2003-03-14 |
2005-06-02 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
CN1791422A
(zh)
|
2003-03-28 |
2006-06-21 |
应用研究系统Ars股份公司 |
凝聚素在治疗和/或预防周围神经疾病中的用途
|
|
US20050255114A1
(en)
|
2003-04-07 |
2005-11-17 |
Nuvelo, Inc. |
Methods and diagnosis for the treatment of preeclampsia
|
|
US20040224914A1
(en)
|
2003-04-18 |
2004-11-11 |
The University Of British Columbia |
Method for treatment of angiogenic disorders
|
|
US20040220131A1
(en)
|
2003-04-18 |
2004-11-04 |
The University Of British Columbia |
Method for treatment of cancerous angiogenic disorders
|
|
CA2527321A1
(en)
*
|
2003-05-30 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for response to egfr inhibitor drugs
|
|
WO2005014849A2
(en)
|
2003-07-03 |
2005-02-17 |
Euro-Celtique, S.A. |
Genes associated with responses to neuropathic pain
|
|
AU2004262369A1
(en)
|
2003-07-29 |
2005-02-10 |
Bristol-Myers Squibb Company |
Biomarkers of cyclin-dependent kinase modulation
|
|
WO2005019258A2
(en)
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
EP1668035A2
(en)
|
2003-09-11 |
2006-06-14 |
Critical Therapeutics, Inc. |
Monoclonal antibodies against hmgb1
|
|
AT412785B
(de)
|
2003-12-04 |
2005-07-25 |
Kungl Andreas J Dr |
Gag-bindungsproteine
|
|
WO2005060457A2
(en)
|
2003-12-04 |
2005-07-07 |
Pdl Biopharma, Inc. |
Treatment of inflammatory bowel diseases with anti-ip-10 antibodies
|
|
GB0329254D0
(en)
|
2003-12-17 |
2004-01-21 |
Univ Manchester |
Treatment of viral infections
|
|
GB0329958D0
(en)
|
2003-12-24 |
2004-01-28 |
Univ Manchester |
Treatment of viral infections
|
|
WO2005071059A2
(en)
|
2004-01-27 |
2005-08-04 |
Compugen Ltd. |
Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby
|
|
US7309487B2
(en)
|
2004-02-09 |
2007-12-18 |
George Inana |
Methods and compositions for detecting and treating retinal diseases
|
|
RU2390353C2
(ru)
*
|
2004-02-12 |
2010-05-27 |
Мерк Патент Гмбх |
Высококонцентрированные жидкие композиции анти-egfr антител
|
|
ITRM20040098A1
(it)
|
2004-02-25 |
2004-05-25 |
Univ Roma |
Anticorpi oligoclonali anticlasterina per la diagnosi di neoplasie e la predizione del loro grado di malignita', metodo diagnostico e kit relativi.
|
|
WO2005094899A1
(en)
|
2004-04-02 |
2005-10-13 |
The University Of British Columbia |
Clusterin antisense therapy for treatment of cancer
|
|
WO2006010047A2
(en)
|
2004-07-09 |
2006-01-26 |
Tripath Imaging, Inc. |
Methods and compositions for the detection of ovarian cancer
|
|
GB0421639D0
(en)
|
2004-09-29 |
2004-10-27 |
Proteome Sciences Plc |
Methods and compositions relating to alzheimer's disease
|
|
JP2008520186A
(ja)
|
2004-10-01 |
2008-06-19 |
マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ |
哺乳類ｅａｇ１イオンチャネルタンパク質に対する新規の抗体
|
|
PT1814595E
(pt)
*
|
2004-11-23 |
2014-04-02 |
Univ British Columbia |
Tratamento de cancro com uma combinação de um agente que perturba a via de sinalização egf e um oligonucleótido que reduz os níveis de clusterina
|
|
US7883858B2
(en)
|
2005-01-27 |
2011-02-08 |
Institute For Systems Biology |
Methods for identifying and monitoring drug side effects
|
|
EP1841874B1
(en)
|
2005-01-27 |
2010-01-06 |
Five Prime Therapeutics, Inc. |
Leader sequences for directing secretion of polypeptides and methods for production thereof
|
|
WO2006089586A1
(en)
|
2005-02-23 |
2006-08-31 |
Medizinische Universität Graz |
Use of a compound with clusterin activity for the treatment of diseases associated with the deposition of abnormal proteins
|
|
JP2008531060A
(ja)
|
2005-03-04 |
2008-08-14 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
相補性決定残基の合理的改変を介して免疫グロブリン可変領域をヒト化する方法
|
|
US20080307537A1
(en)
|
2005-03-31 |
2008-12-11 |
Dana-Farber Cancer Institute, Inc. |
Compositions and Methods for the Identification, Assessment, Prevention, and Therapy of Neurological Diseases, Disorders and Conditions
|
|
US20090203639A1
(en)
|
2005-04-15 |
2009-08-13 |
Oncomethylome Sciences, Inc. |
Methylation Markers for Diagnoses and Treatment of Cancers
|
|
WO2007022248A2
(en)
|
2005-08-16 |
2007-02-22 |
Sloan Kettering Institute For Cancer Research |
Methods of detection of cancer using peptide profiles
|
|
US7612181B2
(en)
*
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP1937815B1
(en)
|
2005-09-13 |
2015-05-13 |
National Research Council of Canada |
Methods and compositions for modulating tumor cell activity
|
|
MX2008004693A
(es)
|
2005-10-21 |
2008-09-03 |
Catalyst Biosciences Inc |
Proteasas modificadas que inhiben la activacion del complemento.
|
|
US7972802B2
(en)
|
2005-10-31 |
2011-07-05 |
University Of Washington |
Lipoprotein-associated markers for cardiovascular disease
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
CA2634146A1
(en)
|
2005-12-19 |
2007-06-28 |
Genizon Biosciences Inc. |
Genemap of the human genes associated with crohn's disease
|
|
WO2007071053A1
(en)
|
2005-12-21 |
2007-06-28 |
Universite De Montreal |
Markers for memory t cells and uses thereof
|
|
KR100679173B1
(ko)
|
2006-02-28 |
2007-02-06 |
주식회사 바이오인프라 |
위암 진단용 단백질 마커 및 이를 이용한 진단키트
|
|
BRPI0709050B1
(pt)
|
2006-03-23 |
2018-12-26 |
Bioarctic Neuroscience Ab |
anticorpo ou fragmento do mesmo, composição, métodos para detectar protofibrilas ab in vitro, e, uso do anticorpo
|
|
WO2007123976A2
(en)
|
2006-04-18 |
2007-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Antibody profiling for determination of patient responsiveness
|
|
JP5244103B2
(ja)
|
2006-08-09 |
2013-07-24 |
ホームステッド クリニカル コーポレイション |
器官特異的蛋白質およびその使用方法
|
|
EP2087152B1
(en)
|
2006-10-27 |
2015-03-11 |
Walfish, Paul |
Endometrial biomarkers
|
|
WO2008085024A1
(en)
|
2007-01-12 |
2008-07-17 |
Erasmus University Medical Center Rotterdam |
Identification and detection of peptides relating to specific disorders
|
|
GB0703652D0
(en)
|
2007-02-26 |
2007-04-04 |
Univ Bradford |
Method for the allosteric modulation of beta1 integrin
|
|
WO2009006382A1
(en)
|
2007-07-02 |
2009-01-08 |
Purdue Research Foundation |
Detection of glycopeptides and glycoproteins for medical diagnostics
|
|
WO2009034562A2
(en)
|
2007-09-11 |
2009-03-19 |
Dublin City University |
A method of assessing lung squamous cell carcinoma status in an individual
|
|
US8617877B2
(en)
|
2007-11-02 |
2013-12-31 |
The Johns Hopkins University |
Cardiac stem cell and myocyte secreted paracrine factors
|
|
US7923253B2
(en)
|
2007-11-05 |
2011-04-12 |
Battelle Memorial Institute |
Method for identifying type I diabetes mellitus in humans
|
|
EP2071336A1
(en)
|
2007-12-13 |
2009-06-17 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Serum proteomic for finding diagnostic markers and for monitoring therapeutical intervention in treatment of hepatocellular carcinoma
|
|
WO2009117030A2
(en)
|
2007-12-19 |
2009-09-24 |
Macrogenics, Inc. |
Improved compositions for the prevention and treatment of smallpox
|
|
EP2080812A1
(en)
|
2008-01-18 |
2009-07-22 |
Transmedi SA |
Compositions and methods of detecting post-stop peptides
|
|
WO2009093246A2
(en)
|
2008-01-22 |
2009-07-30 |
Compugen Ltd. |
Novel clusterin derived peptide
|
|
WO2009116860A1
(en)
|
2008-03-17 |
2009-09-24 |
Vereniging Het Nederlands Kanker Instituut |
Markers providing prognosis of metastasis among cancer patients
|
|
KR101110758B1
(ko)
|
2008-06-02 |
2012-02-15 |
경북대학교 산학협력단 |
뇌졸중 표적용 펩티드 및 이의 용도
|
|
US8148088B2
(en)
|
2008-07-18 |
2012-04-03 |
Abgent |
Regulation of autophagy pathway phosphorylation and uses thereof
|
|
WO2010030980A2
(en)
|
2008-09-12 |
2010-03-18 |
University Of South Florida |
Akt and clusterin as biomarkers of chemotherapeutic responsiveness
|
|
CA2756570C
(en)
|
2009-04-17 |
2019-04-30 |
National Research Council Of Canada |
Peptide ligands for clusterin and uses thereof
|
|
WO2011063523A1
(en)
|
2009-11-24 |
2011-06-03 |
Alethia Biotherapeutics Inc. |
Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
|
|
WO2013123588A1
(en)
|
2012-02-22 |
2013-08-29 |
Alethia Biotherapeutics Inc. |
Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer
|